{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:31:07Z","timestamp":1787682667152,"version":"build-2784847793"},"reference-count":17,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3960\/jslrt.17037","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T22:15:58Z","timestamp":1518041758000},"page":"32-35","source":"Crossref","is-referenced-by-count":16,"title":["Autopsy case report of intravascular large B-cell lymphoma with neoplastic PD-L1 expression"],"prefix":"10.3960","volume":"58","author":[{"given":"Ayako","family":"Sakakibara","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Anjo Kosei Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Imaoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Anjo Kosei Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Satou","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i> WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition edn, International Agency for Research on Cancer. 2017; pp. 317-318."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ponzoni M, Ferreri AJ, Campo E <i>et al.<\/i> Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007; 25: 3168-3173.","DOI":"10.1200\/JCO.2006.08.2313"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Shimada K, Kinoshita T, Naoe T <i>et al.<\/i> Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol. 2009; 10: 895-902.","DOI":"10.1016\/S1470-2045(09)70140-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ilcus C, Bagacean C, Tempescul A <i>et al.<\/i> Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies. Onco Targets Ther. 2017; 10: 2349-2363.","DOI":"10.2147\/OTT.S133385"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Keir ME, Butte MJ, Freeman GJ <i>et al.<\/i> PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008; 26: 677-704.","DOI":"10.1146\/annurev.immunol.26.021607.090331"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chen BJ, Chapuy B, Ouyang J <i>et al.<\/i> PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res. 2013; 19: 3462-3473.","DOI":"10.1158\/1078-0432.CCR-13-0855"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kiyasu J, Miyoshi H, Hirata A <i>et al.<\/i> Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood. 2015; 126: 2193-2201.","DOI":"10.1182\/blood-2015-02-629600"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kwon D, Kim S, Kim PJ <i>et al.<\/i> Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas. Histopathology. 2016; 68: 1079-1089.","DOI":"10.1111\/his.12882"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Menter T, Bodmer-Haecki A, Dirnhofer S <i>et al.<\/i> Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Hum Pathol. 2016; 54: 17-24.","DOI":"10.1016\/j.humpath.2016.03.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Vranic S, Ghosh N, Kimbrough J <i>et al.<\/i> PD-L1 Status in Refractory Lymphomas. PLoS One. 2016; 11: e0166266.","DOI":"10.1371\/journal.pone.0166266"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kwong YL, Chan TSY, Tan D <i>et al.<\/i> PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase. Blood. 2017; 129: 2437-2442.","DOI":"10.1182\/blood-2016-12-756841"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Four M, Cacheux V, Tempier A <i>et al.<\/i> PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival. Hematol Oncol. 2017; 35: 487-496.","DOI":"10.1002\/hon.2375"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Shimada K, Murase T, Matsue K <i>et al.<\/i> Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients. Cancer Sci. 2010; 101: 1480-1486.","DOI":"10.1111\/j.1349-7006.2010.01555.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Matsue K, Hayama BY, Iwama K <i>et al.<\/i> High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer. 2011; 117: 4512-4521.","DOI":"10.1002\/cncr.26090"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hishikawa N, Niwa H, Hara T <i>et al.<\/i> An autopsy case of lymphomatosis cerebri showing pathological changes of intravascular large B-cell lymphoma in visceral organs. Neuropathology. 2011; 31: 612-619.","DOI":"10.1111\/j.1440-1789.2011.01203.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Imai H, Shimada K, Shimada S <i>et al.<\/i> Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma. Pathol Int. 2009; 59: 431-437.","DOI":"10.1111\/j.1440-1827.2009.02390.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Miyoshi H, Kiyasu J, Kato T <i>et al.<\/i> PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood. 2016; 128: 1374-1381.","DOI":"10.1182\/blood-2016-02-698936"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/1\/58_17037\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T14:26:31Z","timestamp":1570717591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/1\/58_17037\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.17037","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}